PROSTATE NEOPLASM
Clinical trials for PROSTATE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new PROSTATE NEOPLASM trials appear
Sign up with your email to follow new studies for PROSTATE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a lower dose of prostate cancer drug work just as well?
Disease control TerminatedThis study looked at whether men with prostate cancer could take a lower dose of the drug abiraterone (combined with prednisone) and still control their cancer. About 50 men who had never taken abiraterone before were enrolled. The goal was to find the smallest dose that still lo…
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 10, 2026 13:24 UTC
-
Experimental cancer drug study halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or with other drugs (olaparib or enzalutamide), in 82 adults with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The goal was to find safe doses and see if the combination worked better. The study was…
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC